dc.creatorMenezes, Raonne Souza Almeida Alves
dc.creatorCastro Filho, Bernardo Galvão
dc.creatorGrassi, Maria Fernanda Rios
dc.date2014-10-01T13:32:18Z
dc.date2014-10-01T13:32:18Z
dc.date2013
dc.date.accessioned2023-09-26T20:44:02Z
dc.date.available2023-09-26T20:44:02Z
dc.identifierMENEZES, R. S. A. A.; CASTRO-FILHO, B. G.; GRASSI, M. F. R. Proviral load of human T-cell of lymphotropic virus type 1 (HTLV-1) and comorbidities in assymptomatic carriers. Brazilian Journal of Medicine and Human Health, v. 2, n. 1, p. 159-163, 2013.
dc.identifier2317-3386
dc.identifierhttps://www.arca.fiocruz.br/handle/icict/8478
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/8862886
dc.descriptionThis study aimed to describe comorbidities and symptoms of asymptomatic HTLV-1 infected patients according to the proviral load. Medical records were revised and patients categorized in high and low proviral load groups: >5% and <5% -infected cells, respectively. Frequency of symptoms was quantified. A total of 64 patients were evaluated. Twenty three (36%) patients had high proviral load. All patients had clinical abnormalities reported in the medical records. The most frequently comorbidities were hypertension (37.5%) and depression (25%) and the most frequent symptoms were neurological (82.8%) and ophthalmologic (65.6%). There were no differences in the frequencies of clinical manifestations in patients with low and high proviral load, except for urinary retention, that was more prevalent in the group with high proviral (34.8%). In summary, patients infected with HTLV-1 asympromatic have a wide spectrum of clinical abnormalities and should be closely followed in order to identify the development of HTLV-1-associated diseases.
dc.formatapplication/pdf
dc.languageeng
dc.publisherEscola Bahiana de Medicina e Saúde Pública
dc.rightsopen access
dc.subjectHuman T-cell lymphotropic virus type 1
dc.subjectProviral load
dc.subjectAsymptomatic carriers
dc.titleProviral load of human T-cell of lymphotropic virus type 1 (HTLV-1) and comorbidities in assymptomatic carriers
dc.typeArticle


Este ítem pertenece a la siguiente institución